Scholars Central

Research articlePublished 2013

The Effect of Smoking on Diagnostic Value of Serum Matrix Metalloproteinase-8 in Acute Coronary Syndrome

Authors: Laura Lahdentausta, Timo Sorsa, Pirkko J Pussinen, Erkki Pesonen

Journal of Molecular Biomarkers & Diagnosis

Volume 4 · Issue 1 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Abstract Background: Smoking has been perceived to increase the levels of carcinogenic and inflammatory mediators thereby promoting presumably malignant and proinflammatory tissue destruction via activating proteolytic enzymes such as matrix metalloproteinases (MMPs) and their regulators. We studied the effect of smoking on the diagnostic ability of serum MMP-8-IFMA and TIMP-1-ELISA analysis to recognize patients with acute coronary syndrome (ACS). Methods: The case-control population (n=605) comprised 291 patients with diagnosed acute myocardial infarction (AMI) or unstable angina pectoris (UAP) and 314 healthy control individuals. The case and the control group included 55 and 66 smoking subjects, respectively. Results: Smoking increased the MMP-8, but not the TIMP-1, concentration in both the control and the AMI group. MMP-8 concentration, and consequently MMP-8/TIMP-1, distinguished the cases from the controls accurately in the ROC analysis, but smoking decreased the AUCs in every category. The MMP-8 concentration produced an AUC (95% CI, p-value) for ACS of 0.771 (0.723-0.818, p<0.001) and 0.684 (0.581-0.787, p=0.001) for non-smokers and smokers, respectively. Similarly, the multivariate logistic regression model indicated that smoking decreased the association of MMP-8 with ACS. The OR (95% CI, p-value) of MMP-8 for ACS was 8.1 (per ng/ml log-transformed unit increase, 5.0-13.1, p<0.001) and 2.8 (1.1-7.0, p=0.025) for non-smokers and smokers, respectively. Conclusions: One of the most important risk factors for ACS, smoking, decreases the diagnostic ability of MMP- 8 concentration and MMP-8/TIMP-1 ratio. This must be taken account if these serum determinations are used as biomarkers of the risk for cardiovascular diseases.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Molecular Biomarkers & Diagnosis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Biomarkers & Diagnosis
  • SubjectGenetics & Molecular Biology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Laura Lahdentausta”
  • BylineArticles whose byline prints “Timo Sorsa”
  • BylineArticles whose byline prints “Pirkko J Pussinen”
  • BylineArticles whose byline prints “Erkki Pesonen”